Two experimental compounds could benefit people living with multiple sclerosis

Multiple sclerosis (MS) is a chronic autoimmune disease affecting more than 2.9 million people worldwide. It occurs when the immune system mistakenly attacks the myelin sheath, the protective insulation around nerve fibers, causing disruption of nerve signals between the brain and body. Symptoms can include numbness, tingling, vision loss, and paralysis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup